Subscribe
‘Enforcement 40’ for 2020
Our Sponsors
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedInLife Sciences Companies Remained Frequent Securities Suit Targets in 2022 | The D&O Diary
The number of securities class action lawsuits filed against life sciences companies in 2022 declined compared to 2021 but remained relatively steady as a proportion of the total number of securities class action lawsuits filed during the year, according to a new report from the Dechert law firm. The report, entitled “Dechert Survey 2022 Edition: […]
Life Sciences Companies: Frequent Securities Suits Frequently Dismissed | The D&O Diary
As I have documented in prior posts (for example, here), publicly traded life sciences companies are frequent targets of securities class action lawsuits. But life sciences companies’ securities litigation exposure may be well-known, it is not always as appreciated that the securities suits against life sciences companies are often dismissed. Two recent rulings in securities […]
Dechert Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences Companies — Dechert LLP
Report highlights securities fraud class action lawsuits against life sciences companies.